Literature DB >> 23804257

Genetic analysis of type 1 diabetes: embryonic stem cells as new tools to unlock biological mechanisms in type 1 diabetes.

Nick Holmes1, Anne Cooke.   

Abstract

The nonobese diabetic (NOD) mouse has provided an important animal model for studying the mechanism and genetics of type 1 diabetes over the past 30 years. Arguably, the bio-breeding (BB) rat model may be an even closer phenotypic mimic of the typical human disease. A large number of distinct genetic traits which influence diabetes development have been defined through an extraordinary effort, most conspicuously in the mouse model. However, in both NOD and BB models the lack of availability of robust means for experimental genetic manipulation has restricted our understanding of the mechanisms underlying this spontaneous autoimmune disease. Recent developments in the derivation of embryonic stem (ES) cells have the potential to transform this picture. We argue here that targeting of NOD strain ES cells can bring much needed certainty to our present understanding of the genetics of type 1 diabetes in the NOD mouse. In addition, ES cells can play important roles in the future, in both the NOD mouse and BB rat models, through the generation of new tools to investigate the mechanisms by which genetic variation acts to promote diabetes.

Entities:  

Mesh:

Year:  2012        PMID: 23804257      PMCID: PMC3740687          DOI: 10.1900/RDS.2012.9.137

Source DB:  PubMed          Journal:  Rev Diabet Stud        ISSN: 1613-6071


  60 in total

1.  Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity.

Authors:  Jun Yamanouchi; Dan Rainbow; Pau Serra; Sarah Howlett; Kara Hunter; Valerie E S Garner; Andrea Gonzalez-Munoz; Jan Clark; Riitta Veijola; Rose Cubbon; Show-Ling Chen; Raymond Rosa; Anne Marie Cumiskey; David V Serreze; Simon Gregory; Jane Rogers; Paul A Lyons; Barry Healy; Luc J Smink; John A Todd; Laurence B Peterson; Linda S Wicker; Pere Santamaria
Journal:  Nat Genet       Date:  2007-02-04       Impact factor: 38.330

2.  Knockout rats generated by embryo microinjection of TALENs.

Authors:  Laurent Tesson; Claire Usal; Séverine Ménoret; Elo Leung; Brett J Niles; Séverine Remy; Yolanda Santiago; Anna I Vincent; Xiangdong Meng; Lei Zhang; Philip D Gregory; Ignacio Anegon; Gregory J Cost
Journal:  Nat Biotechnol       Date:  2011-08-05       Impact factor: 54.908

3.  Engineering the mouse genome with bacterial artificial chromosomes to create multipurpose alleles.

Authors:  Giuseppe Testa; Youming Zhang; Kristina Vintersten; Vladimir Benes; W W M Pim Pijnappel; Ian Chambers; Andrew J H Smith; Austin G Smith; A Francis Stewart
Journal:  Nat Biotechnol       Date:  2003-03-10       Impact factor: 54.908

4.  Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain.

Authors:  T Lund; L O'Reilly; P Hutchings; O Kanagawa; E Simpson; R Gravely; P Chandler; J Dyson; J K Picard; A Edwards
Journal:  Nature       Date:  1990-06-21       Impact factor: 49.962

5.  "Agouti NOD": identification of a CBA-derived Idd locus on Chromosome 7 and its use for chimera production with NOD embryonic stem cells.

Authors:  Jing Chen; Peter C Reifsnyder; Felix Scheuplein; William H Schott; Maria Mileikovsky; Sharon Soodeen-Karamath; Andras Nagy; Michael H Dosch; James Ellis; Friedrich Koch-Nolte; Edward H Leiter
Journal:  Mamm Genome       Date:  2005-10-29       Impact factor: 2.957

6.  Amino acid polymorphisms altering the glycosylation of IL-2 do not protect from type 1 diabetes in the NOD mouse.

Authors:  Masahito Kamanaka; Dan Rainbow; Karin Schuster-Gossler; Elizabeth E Eynon; Alexander V Chervonsky; Linda S Wicker; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-22       Impact factor: 11.205

7.  Interleukin-21 receptor-mediated signals control autoreactive T cell infiltration in pancreatic islets.

Authors:  Tom L Van Belle; Stefan Nierkens; Ramon Arens; Matthias G von Herrath
Journal:  Immunity       Date:  2012-05-10       Impact factor: 31.745

8.  The nonconventional MHC class II molecule DM governs diabetes susceptibility in NOD mice.

Authors:  Marc A J Morgan; Pari S S Muller; Arne Mould; Stephen A Newland; Jennifer Nichols; Elizabeth J Robertson; Anne Cooke; Elizabeth K Bikoff
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

9.  Improved experimental procedures for achieving efficient germ line transmission of nonobese diabetic (NOD)-derived embryonic stem cells.

Authors:  Satoko Arai; Christina Minjares; Seiho Nagafuchi; Toru Miyazaki
Journal:  Exp Diabesity Res       Date:  2004 Jul-Sep

10.  Type 1 diabetes in the BB rat: a polygenic disease.

Authors:  Robert H Wallis; KeSheng Wang; Leili Marandi; Eugene Hsieh; Terri Ning; Gary Y C Chao; Janice Sarmiento; Andrew D Paterson; Philippe Poussier
Journal:  Diabetes       Date:  2009-01-23       Impact factor: 9.461

View more
  2 in total

1.  A SNP in the Immunoregulatory Molecule CTLA-4 Controls mRNA Splicing In Vivo but Does Not Alter Diabetes Susceptibility in the NOD Mouse.

Authors:  Fabian Jakubczik; Ken Jones; Jennifer Nichols; William Mansfield; Anne Cooke; Nick Holmes
Journal:  Diabetes       Date:  2015-10-08       Impact factor: 9.461

2.  The Vbeta13 T Cell Receptor Monoclonal Antibody Reduces Hyaluronan and CD68+, CD3+, and CD8+ Cell Infiltrations to Delay Diabetes in Congenic BB DRLyp/Lyp Rats.

Authors:  Marika Bogdani; Linda Faxius; Malin Fex; Anita Ramelius; Anya Wernersson; John P Mordes; Elizabeth P Blankenhorn; Åke Lernmark
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-16       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.